TY - JOUR

T1 - Challenges in secondary prevention after acute myocardial infarction

T2 - A call for action

AU - Piepoli, Massimo F

AU - Corrà, Ugo

AU - Dendale, Paul

AU - Frederix, Ines

AU - Prescott, Eva

AU - Schmid, Jean Paul

AU - Cupples, Margaret

AU - Deaton, Christi

AU - Doherty, Patrick

AU - Giannuzzi, Pantaleo

AU - Graham, Ian

AU - Hansen, Tina Birgitte

AU - Jennings, Catriona

AU - Landmesser, Ulf

AU - Marques-Vidal, Pedro

AU - Vrints, Christiaan

AU - Walker, David

AU - Bueno, Hector

AU - Fitzsimons, Donna

AU - Pelliccia, Antonio

PY - 2017/6

Y1 - 2017/6

N2 - Worldwide, each year more than 7 million people experience myocardial infarction, in which one-year mortality rates are now in the range of 10%, but vary with patient characteristics. The consequences are even more dramatic: among patients who survive, 20% suffer a second cardiovascular event in the first year and approximately 50% of major coronary events occur in those with a previous hospital discharge diagnosis of ischaemic heart disease. The people behind these numbers spur this call for action. Prevention after myocardial infarction is crucial to reduce risk and suffering. Evidence-based interventions include optimal medical treatment with anti-platelets and statins, achievement of blood pressure, lipid and blood glucose targets, and appropriate lifestyle changes. The European Society of Cardiology and its constituent bodies are determined to embrace this challenge by developing a consensus document in which the existing gaps for secondary prevention strategies are reviewed. Effective interventions in relation to the patients, healthcare providers and healthcare systems are proposed and discussed. Finally, innovative strategies in hospital as well as in outpatient and long-term settings are endorsed.

AB - Worldwide, each year more than 7 million people experience myocardial infarction, in which one-year mortality rates are now in the range of 10%, but vary with patient characteristics. The consequences are even more dramatic: among patients who survive, 20% suffer a second cardiovascular event in the first year and approximately 50% of major coronary events occur in those with a previous hospital discharge diagnosis of ischaemic heart disease. The people behind these numbers spur this call for action. Prevention after myocardial infarction is crucial to reduce risk and suffering. Evidence-based interventions include optimal medical treatment with anti-platelets and statins, achievement of blood pressure, lipid and blood glucose targets, and appropriate lifestyle changes. The European Society of Cardiology and its constituent bodies are determined to embrace this challenge by developing a consensus document in which the existing gaps for secondary prevention strategies are reviewed. Effective interventions in relation to the patients, healthcare providers and healthcare systems are proposed and discussed. Finally, innovative strategies in hospital as well as in outpatient and long-term settings are endorsed.

KW - Journal Article

U2 - 10.1177/2048872616689773

DO - 10.1177/2048872616689773

M3 - Review

VL - 6

SP - 299

EP - 310

JO - European Heart Journal: Acute Cardiovascular Care

JF - European Heart Journal: Acute Cardiovascular Care

SN - 2048-8726

IS - 4

ER -